INZY NASDAQ
Inozyme Pharma, Inc.
1W: +0.2%
1M: +0.5%
3M: +359.8%
1Y: -10.3%
3Y: -22.5%
$4.00
Last traded 2025-07-02 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-107M
Net Income
-38.4% YoY
$-97M
Free Cash Flow
-24.4% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-141.7%
ROA-78.4%
ROIC1408.1%
Valuation
P/E-2.5
P/B4.3
EV/EBITDA-0.2
Leverage
Debt/Equity1.48
Current Ratio2.19
Interest Cov.-17.9x
Quality Scores
Piotroski F1/9
Altman Z-8.43
Beneish M0.00